On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayJul 13, 2021 4:20 pm

420 with CNW — An Overview of CBD Patches Used for Pain

Cannabidiol, a nonpsychoactive cannabinoid produced by hemp and cannabis, has been receiving plenty of mainstream attention lately because of its supposed medicinal properties. Anecdotal claims as well as preliminary studies say that it can treat everything from anxiety and insomnia to chronic pain and epilepsy, but its ability to alleviate pain has taken center stage. Several studies, most of them on animals, have found that CBD can treat pain caused by numerous medical conditions. Cannabidiol itself can be consumed in a wide variety of ways, but when it comes to treating pain, CBD patches take the cake. These transdermal patches…

Continue Reading

TuesdayJul 13, 2021 10:19 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Line of Products Addresses Declining Minerals in Food Supply

Soil depletion causing mineral loss in food supply BevCanna’s TRACE line of products address issue through proprietary plant-based formula rich in iron, magnesium, calcium, potassium Company recently signed distribution agreement to reach target markets in New York, Chicago, California BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, helps consumers address nutrient deficiencies with its TRACE line of beverages and supplements. Sourced from deep within British Columbia’s Rocky Mountains, TRACE products are high in fulvic and humic minerals, providing an easily absorbed source of minerals such as iron, magnesium, calcium, potassium…

Continue Reading

TuesdayJul 13, 2021 4:20 am

420 with CNW — House Committee Backs Using Drones for Identifying Illicit Marijuana Grows

More than a decade after launching a state-legal cannabis industry, America's illicit cannabis market is still going strong. One of the objectives of legalizing marijuana was to draw clientele away from the black market and deprive the criminal organizations behind it of revenue from cannabis sales, but most states have failed to do major damage to illicit cannabis sales. To add insult to injury, a large percentage of illegal marijuana is grown on public land, and since cannabis is a water-intensive plant, these illegal grows tend to steal a lot of water as well. In a bid to curb the…

Continue Reading

MondayJul 12, 2021 4:20 pm

420 with CNW — House Committee Witness Urges Legislators to Make Bipartisan Visits to Cannabis Businesses

The legalization of cannabis has become popular in America, with 18 states having legalized the recreational use of the herb and another 13 decriminalizing its use. However, while Congress is still in disagreement about the herb, a recent visit from an investigative reporter may help move things along. Amanda Ripley, the witness who graced a House Committee hearing, suggested visits to cannabis businesses by ideologically opposed legislators. Similar visits have happened in Canada, when MP Garnett Genius and Nathaniel Erskine-Smith visited a major producer of cannabis in 2017. This came right before the country legalized the herb for recreational use…

Continue Reading

MondayJul 12, 2021 11:31 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delists from CSE to Focus Efforts on Most Effective Drug Platform Outcomes

Lexaria Bioscience is a drug bioavailability platform developer intent on providing an effective oral administration alternative to smoking that duplicates the rapid assimilation benefits of inhalation without the lung-harmful effects The company’s DehydraTECH IP is being evaluated for concentration levels, tolerability and ability to transform partner drugs to oral solutions without incidentally creating new molecular entities Lexaria announced voluntary delisting from the Canadian Securities Exchange this month in order to focus its resources more effectively on its Nasdaq listing The company’s leadership recently interacted with investors in the Life Sciences Investor Forum virtual conference series and the company’s annual meeting…

Continue Reading

MondayJul 12, 2021 4:20 am

420 with CNW — Cannabis Legalization Creates Boom for Veterans as Security Guards

America's state-legal cannabis industry has achieved quite a lot in a little over a decade. Generating billions of dollars in revenue, it has created hundreds of thousands of new job opportunities and provided states with millions in tax revenue. The industry is projected to grow even larger as it matures and more states join; one group of people who are poised to benefit from the cannabis legalization boom are military veterans. Cannabis' federal classification as a Schedule I regulated substance has prevented banks and credit card processors from working with businesses in the cannabis space. This has forced these companies…

Continue Reading

FridayJul 09, 2021 4:20 pm

420 with CNW — Five Ingredients That Could Dominate the 2021 Supplement Space

Last year saw a significant rise in the demand for quality dietary supplements. The coronavirus pandemic prompted millions of individuals to look for supplements that support immune function and also spurred a change in the way consumers thought about protecting their health. New reports show that more than 80% of Americans are now consuming dietary supplements. However, the products seem to differ when it comes to demographics, as different generations seek out supplements that address various wellness concerns. For instance, millennials are looking for natural ways to decrease the effects of stress, fight anxiety and grow their mental stamina while…

Continue Reading

FridayJul 09, 2021 4:20 am

420 with CNW — Congress Gears Up to Consider Spending Bills Touching on Marijuana, CBD and Hemp

Just a day after the House Appropriations Committee released a report urging federal agencies to reconsider firing employees for past cannabis use, several cannabis and hemp-related spending bills have advanced in Congress. As the 2022 midterms approach, Democrats have limited time to advance cannabis legislation before the Republican Party challenges their tenuous hold on Congress. If these bills are successful, they could have far-reaching effects on the cannabis and hemp industries. For starters, the House Appropriations Committee approved a bill with an attached report acknowledging clarification from the U.S. Department of Veterans Affairs (“VA”) that veterans who work in the…

Continue Reading

ThursdayJul 08, 2021 4:20 pm

420 with CNW — Study Finds That Marijuana Possesses Strain-Specific Effect on Driving Performance

A recent study has found that drivers who consume marijuana may not perform or feel impaired. The study found that, instead, drivers who used marijuana would sometimes experience a positive effect on their driving. This comes at a time when policy makers are working to decide whether driving while under the influence of marijuana warrants similar penalties to driving while under the influence of alcohol in various states across the country. Under the law, impairment is defined as a state of diminished or weakened function. In many states, the legal limit for blood–alcohol content is 0.08. It is known that…

Continue Reading

ThursdayJul 08, 2021 12:04 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive Results From its Recent Animal Study on the Effectiveness of its DehydraTECH Drug Delivery Technology

Lexaria Bioscience Corp. announced positive results from its VIRAL-A20-2 study This study showed strong gains in delivery of the DehydraTECH-enabled remdesivir and ebastine among animals The success of this study shows the potential and commercial viability of Lexaria’s DehydraTECH In June 2021, Lexaria Bioscience (NASDAQ: LEXX) announced positive results from its VIRAL-A20-2 study that evaluated the effectiveness of DehydraTECH-enabled remdesivir and ebastine among animals. The results were strongly positive and demonstrated greater effectiveness than in Lexaria’s first antiviral drug study reported in December 2000. The research was a tolerability and pharmacokinetic (“PK”) study involving four groups of 10 animals each.…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722